首页 > 最新文献

中国药理学通报最新文献

英文 中文
Clinical characteristics and treatment strategies of 79 patients with COVID-19 79例新冠肺炎患者的临床特点及治疗对策
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2020-04-01 DOI: 10.3969/J.ISSN.1001-1978.2020.04.002
Xiaowei Fang, Q. Mei, Tian-jun Yang, Lei Zhang, Yun Yang, Yin Wang, Fei Tong, Chongyang Ye, Yu Gao, Yao Huang, Shike Geng, A. Pan
Aim To analyze the clinical characteristics of patients of corona virus disease 2019 (COVID-19), and summarize the treatment experience, aiming to provide diagnostic and treatment reference for the front-line clinicians Methods Seventy-nine patients with COVID-19 admitted to the Infectious Hospital of Anhui Provincial Hospital from January 22 to February 18, 2020 were selected as the research subjects There were 55 cases in general group and 24 cases in severe and critical group The clinical data of the two groups were collected and compared, including general conditions, clinical symptoms, signs, laboratory tests, computed tomography imaging of the lungs and complications Results The average age of 79 COVID-19 patients was 45 1 ± 16 6 years, and forty-five of them are males The severe and critical group was older than the general group Besides, there were more males and comorbidities In terms of laboratory tests, the lymphocyte (LYM) count and albumin (A L B) decreased more significantly in the severe and critical groups Moreover, the percentage of neutrophils (N E U), c-reactive protein (CRP), D-dimer, lactate dehydrogenase (L D H), troponin I (cTnl) and urea nitrogen (BUN) increased significantly Among all the patients, the types of antiviral drugs in severe and critical group were significantly more than those in general group;moreover, the glucocorticoids, gamma globulin and oxygen inhalation by nasal catheter were used more frequently in severe and critical patients By the time of February 18, one patient died of acute large area cerebral infarction, 34 patients were discharged from hospital, and the rest were still receiving treatment Conclusions The elderly patients with multiple cardiovascular diseases are more likely to get severe and critical COVID-19 They usually combine multiple organ or system abnormalities Clinicians should make timely judgment and adjust the treatment plan according to the clinical symptoms, signs and laboratory examination results
目的分析2019冠状病毒病(COVID-19)患者的临床特征,总结治疗经验,旨在为一线临床医生提供诊断和治疗参考方法1月22日至2月18日安徽省立医院感染性医院收治的79例COVID-19患者,2020年被选为研究对象一般有55例组,24例严重和重要组两组临床资料的收集和比较,包括一般情况、临床症状、体征、实验室测试、计算机断层扫描成像的肺部和并发症结果79 COVID-19患者的平均年龄是45 1±16 6年,其中45是男性严重和重要组比一般群体之外,在实验室检查方面,重症和危重症组淋巴细胞(LYM)计数和白蛋白(A L B)下降更为明显,中性粒细胞(N E U)、c反应蛋白(CRP)、D-二聚体、乳酸脱氢酶(L D H)、肌钙蛋白I (cTnl)和尿素氮(BUN)百分比均显著升高。重症、危重症患者使用抗病毒药物的种类明显多于普通组,且重症、危重症患者使用糖皮质激素、丙种球蛋白、鼻导管吸氧的频率更高。截至2月18日,1例患者死于急性大面积脑梗死,34例患者出院。结论老年合并多种心血管疾病的患者更易发生重症、危重型新冠肺炎,多合并多器官或系统异常,临床医生应根据临床症状、体征及实验室检查结果,及时判断并调整治疗方案
{"title":"Clinical characteristics and treatment strategies of 79 patients with COVID-19","authors":"Xiaowei Fang, Q. Mei, Tian-jun Yang, Lei Zhang, Yun Yang, Yin Wang, Fei Tong, Chongyang Ye, Yu Gao, Yao Huang, Shike Geng, A. Pan","doi":"10.3969/J.ISSN.1001-1978.2020.04.002","DOIUrl":"https://doi.org/10.3969/J.ISSN.1001-1978.2020.04.002","url":null,"abstract":"Aim To analyze the clinical characteristics of patients of corona virus disease 2019 (COVID-19), and summarize the treatment experience, aiming to provide diagnostic and treatment reference for the front-line clinicians Methods Seventy-nine patients with COVID-19 admitted to the Infectious Hospital of Anhui Provincial Hospital from January 22 to February 18, 2020 were selected as the research subjects There were 55 cases in general group and 24 cases in severe and critical group The clinical data of the two groups were collected and compared, including general conditions, clinical symptoms, signs, laboratory tests, computed tomography imaging of the lungs and complications Results The average age of 79 COVID-19 patients was 45 1 ± 16 6 years, and forty-five of them are males The severe and critical group was older than the general group Besides, there were more males and comorbidities In terms of laboratory tests, the lymphocyte (LYM) count and albumin (A L B) decreased more significantly in the severe and critical groups Moreover, the percentage of neutrophils (N E U), c-reactive protein (CRP), D-dimer, lactate dehydrogenase (L D H), troponin I (cTnl) and urea nitrogen (BUN) increased significantly Among all the patients, the types of antiviral drugs in severe and critical group were significantly more than those in general group;moreover, the glucocorticoids, gamma globulin and oxygen inhalation by nasal catheter were used more frequently in severe and critical patients By the time of February 18, one patient died of acute large area cerebral infarction, 34 patients were discharged from hospital, and the rest were still receiving treatment Conclusions The elderly patients with multiple cardiovascular diseases are more likely to get severe and critical COVID-19 They usually combine multiple organ or system abnormalities Clinicians should make timely judgment and adjust the treatment plan according to the clinical symptoms, signs and laboratory examination results","PeriodicalId":10296,"journal":{"name":"中国药理学通报","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44840642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 31
The research progress ot nanomedicme tor lmmunomodulation therapy 纳米药物免疫调节治疗的研究进展
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-02-01 DOI: 10.3969/J.ISSN.1001-1978.2017.02.003
X. Wang, L. Tang, Jun Wang, Yang Shu, Yi Wang
{"title":"The research progress ot nanomedicme tor lmmunomodulation therapy","authors":"X. Wang, L. Tang, Jun Wang, Yang Shu, Yi Wang","doi":"10.3969/J.ISSN.1001-1978.2017.02.003","DOIUrl":"https://doi.org/10.3969/J.ISSN.1001-1978.2017.02.003","url":null,"abstract":"","PeriodicalId":10296,"journal":{"name":"中国药理学通报","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44810896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of chemokine MCP-1 on NMDA-mediated exciatory postsynaptic current in hippocampal slice of rats 趋化因子MCP-1对nmda介导的大鼠海马皮层兴奋性突触后电流的影响
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2016-07-01 DOI: 10.3969/J.ISSN.1001-1978.2016.07.013
Shan Li, Zheng-quan Hu, Yan Zhou, Huan Xiong
{"title":"Effects of chemokine MCP-1 on NMDA-mediated exciatory postsynaptic current in hippocampal slice of rats","authors":"Shan Li, Zheng-quan Hu, Yan Zhou, Huan Xiong","doi":"10.3969/J.ISSN.1001-1978.2016.07.013","DOIUrl":"https://doi.org/10.3969/J.ISSN.1001-1978.2016.07.013","url":null,"abstract":"","PeriodicalId":10296,"journal":{"name":"中国药理学通报","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70068390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress of relationship between DNA homologous recombination repair and breast cancer DNA同源重组修复与乳腺癌关系的研究进展
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2016-07-01 DOI: 10.3969/J.ISSN.1001-1978.2016.07.006
Y. Qiu, Yun Hu, Jin Zhang
{"title":"Research progress of relationship between DNA homologous recombination repair and breast cancer","authors":"Y. Qiu, Yun Hu, Jin Zhang","doi":"10.3969/J.ISSN.1001-1978.2016.07.006","DOIUrl":"https://doi.org/10.3969/J.ISSN.1001-1978.2016.07.006","url":null,"abstract":"","PeriodicalId":10296,"journal":{"name":"中国药理学通报","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70068382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Chronic intermittent hypobaric hypoxia ameliorates myocardial apoptosis through inhibiting mitochondrial pathway in rats with metabolism syndrome 慢性间歇性低压缺氧通过抑制线粒体通路改善代谢综合征大鼠心肌凋亡
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2015-08-01 DOI: 10.3969/J.ISSN.1001-1978.2015.08.021
F. Yuan, Yan Li, X. Teng, Jing-jing Zhou, Zan Guo, Xin Wang, Z. Zhang, Yi Zhang
{"title":"Chronic intermittent hypobaric hypoxia ameliorates myocardial apoptosis through inhibiting mitochondrial pathway in rats with metabolism syndrome","authors":"F. Yuan, Yan Li, X. Teng, Jing-jing Zhou, Zan Guo, Xin Wang, Z. Zhang, Yi Zhang","doi":"10.3969/J.ISSN.1001-1978.2015.08.021","DOIUrl":"https://doi.org/10.3969/J.ISSN.1001-1978.2015.08.021","url":null,"abstract":"","PeriodicalId":10296,"journal":{"name":"中国药理学通报","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2015-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70068377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress of phosphodiesterases and phosphodiesterase inhibitors 磷酸二酯酶及磷酸二酯酶抑制剂的研究进展
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2014-02-01 DOI: 10.3969/J.ISSN.1001-1978.2014.02.031
C. Chen, Shuang‐Quan Huang
Intracellular levels of ubiquitous transduction signal cyclic adenosine 3',5'-monophosphate( cAMP) and cyclic guanosine 3',5'-monophosphate( cGMP) are partly determined by the hydrolysis by phosphodiesterases( PDEs). So far,the superfamily of PDE is composed of at least 11 isoforms and each family is characterized with unique cellular distribution,expression,regulation mode and inhibitor sensitivity,and PDEs are considered to be involved in a variety of pathological processes, such as inflammation,asthma,depression,and erectile dysfunction,etc. Currently,these characteristics draw PDEs more and more attention as great targets for drugs. In this review,the basic biochemical properties,cellular regulation,expression pattern,physiological functions and inhibitors of different PDE isoforms will be briefly discussed.
细胞内普遍存在的转导信号环腺苷3′,5′-单磷酸(cAMP)和环鸟苷3′,5′-单磷酸(cGMP)的水平部分由磷酸二酯酶(PDEs)的水解决定。迄今为止,PDE超家族至少由11个亚型组成,每个家族都具有独特的细胞分布、表达、调控模式和抑制剂敏感性,PDE被认为参与多种病理过程,如炎症、哮喘、抑郁、勃起功能障碍等。目前,PDEs作为药物的重要靶点越来越受到人们的关注。本文就不同PDE亚型的基本生化特性、细胞调控、表达模式、生理功能及抑制因子等方面进行综述。
{"title":"Research progress of phosphodiesterases and phosphodiesterase inhibitors","authors":"C. Chen, Shuang‐Quan Huang","doi":"10.3969/J.ISSN.1001-1978.2014.02.031","DOIUrl":"https://doi.org/10.3969/J.ISSN.1001-1978.2014.02.031","url":null,"abstract":"Intracellular levels of ubiquitous transduction signal cyclic adenosine 3',5'-monophosphate( cAMP) and cyclic guanosine 3',5'-monophosphate( cGMP) are partly determined by the hydrolysis by phosphodiesterases( PDEs). So far,the superfamily of PDE is composed of at least 11 isoforms and each family is characterized with unique cellular distribution,expression,regulation mode and inhibitor sensitivity,and PDEs are considered to be involved in a variety of pathological processes, such as inflammation,asthma,depression,and erectile dysfunction,etc. Currently,these characteristics draw PDEs more and more attention as great targets for drugs. In this review,the basic biochemical properties,cellular regulation,expression pattern,physiological functions and inhibitors of different PDE isoforms will be briefly discussed.","PeriodicalId":10296,"journal":{"name":"中国药理学通报","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70068321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recombination and purification of IL-23 gene and its effect on immune response to airway inflammation in asthma during pregnancy IL-23基因重组纯化及其对妊娠期哮喘气道炎症免疫应答的影响
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2014-01-01 DOI: 10.3969/J.ISSN.1001-1978.2014.03.019
Jia-jia Ma, N. Lu, Bi-liang Chen
Aim To investigate the immune regulation of IL-23 fusion gene and the correlation between its biological function and the airway inflammation in asthma during pregnancy. Methods The eukaryotic expression plasmid,which was constructed to express the IL-23p40 + p19 double subunit,was used to transform E.coilBL21 bacteria,and the expression products,which were induced by IPTG,were purified and detected by SDS-PAGE and Western blot. The transfection,mediated by recombinant protein,was identified by fluorescence microscopy and plasmid's Western blot,while DNA binding activity of nuclear proteins was measured by gel electrophoresis. To evaluate the impact of foreign protein in vivo,mouse serum inflammatory cytokines levels and inflammation injury in lung tissue were measured by ELISA method and HE staining. The CD4+T cell subset's proportion of mononuclear cells in peripheral blood was verified by flow cytometry. Results The results showed that soluble exogenous recombinant protein,which was obtained successfully,had the ability of trans-membrane transport and could effectively mediate EGFP into the target cells. Its stable expression and transcriptional activity were higher than those of simple plasmid's effect. The specific binding between GST/pCEP4-IL-23 and plasmid DNA formed macromolecular complexes,which could decrease the mobility of gel. The combined effect with LPS significantly increased the IL-17A levels in serum(P 0. 05) and the inflammation reaction in lung tissue of sensitized mice. Mean while,it also reduced the IFN-γ,Foxp3 level in serum,promoted the activation of IL-4 and IL-17A,and then increased the ratio of Th2/Th1and Th17/Treg(P 0. 05). Conclusions The recombinant IL-23 protein is pathogenic,and it adjusts the inflammation of asthma in pregnancy. The immune imbalance of CD4+T subsets affects the immune tolerance of pregnant body and the development of asthma during pregnancy.
目的探讨IL-23融合基因的免疫调控及其生物学功能与妊娠哮喘气道炎症的关系。方法构建表达IL-23p40 + p19双亚基的真核表达质粒,转化大肠杆菌E.coilBL21,经IPTG诱导纯化表达产物,采用SDS-PAGE和Western blot检测。通过荧光显微镜和质粒Western blot检测重组蛋白介导的转染,凝胶电泳检测核蛋白的DNA结合活性。为了评价外源蛋白对体内的影响,采用ELISA法和HE染色法检测小鼠血清炎症因子水平和肺组织炎症损伤。流式细胞术检测外周血CD4+T细胞亚群占单核细胞的比例。结果成功获得的可溶性外源重组蛋白具有跨膜转运能力,能有效介导EGFP进入靶细胞。其稳定表达和转录活性均高于单纯质粒效应。GST/ ppcep4 - il -23与质粒DNA特异性结合形成大分子复合物,降低凝胶的迁移率。联合LPS显著提高了大鼠血清IL-17A水平(P < 0.05)。05)及致敏小鼠肺组织炎症反应。同时降低血清中IFN-γ、Foxp3水平,促进IL-4、IL-17A活化,进而提高Th2/ th1、Th17/Treg比值(P < 0.05)。05). 结论重组IL-23蛋白具有致病性,可调节妊娠期哮喘的炎症反应。CD4+T亚群免疫失衡影响孕妇机体免疫耐受,影响妊娠期哮喘的发生。
{"title":"Recombination and purification of IL-23 gene and its effect on immune response to airway inflammation in asthma during pregnancy","authors":"Jia-jia Ma, N. Lu, Bi-liang Chen","doi":"10.3969/J.ISSN.1001-1978.2014.03.019","DOIUrl":"https://doi.org/10.3969/J.ISSN.1001-1978.2014.03.019","url":null,"abstract":"Aim To investigate the immune regulation of IL-23 fusion gene and the correlation between its biological function and the airway inflammation in asthma during pregnancy. Methods The eukaryotic expression plasmid,which was constructed to express the IL-23p40 + p19 double subunit,was used to transform E.coilBL21 bacteria,and the expression products,which were induced by IPTG,were purified and detected by SDS-PAGE and Western blot. The transfection,mediated by recombinant protein,was identified by fluorescence microscopy and plasmid's Western blot,while DNA binding activity of nuclear proteins was measured by gel electrophoresis. To evaluate the impact of foreign protein in vivo,mouse serum inflammatory cytokines levels and inflammation injury in lung tissue were measured by ELISA method and HE staining. The CD4+T cell subset's proportion of mononuclear cells in peripheral blood was verified by flow cytometry. Results The results showed that soluble exogenous recombinant protein,which was obtained successfully,had the ability of trans-membrane transport and could effectively mediate EGFP into the target cells. Its stable expression and transcriptional activity were higher than those of simple plasmid's effect. The specific binding between GST/pCEP4-IL-23 and plasmid DNA formed macromolecular complexes,which could decrease the mobility of gel. The combined effect with LPS significantly increased the IL-17A levels in serum(P 0. 05) and the inflammation reaction in lung tissue of sensitized mice. Mean while,it also reduced the IFN-γ,Foxp3 level in serum,promoted the activation of IL-4 and IL-17A,and then increased the ratio of Th2/Th1and Th17/Treg(P 0. 05). Conclusions The recombinant IL-23 protein is pathogenic,and it adjusts the inflammation of asthma in pregnancy. The immune imbalance of CD4+T subsets affects the immune tolerance of pregnant body and the development of asthma during pregnancy.","PeriodicalId":10296,"journal":{"name":"中国药理学通报","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70068325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reversal effects of milbemycins on multidrug resistance in MCF-7/adr cells 米贝霉素对MCF-7/adr细胞多药耐药的逆转作用
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2013-10-01 DOI: 10.3969/J.ISSN.1001-1978.2013.10.019
Aili Gao, Hongsheng Liang, Zhao Wang, Shuai Liu, Qing Wang, Ning Zhao
Aim To explore the reversal of MDR(multidrug resistance) by nemadectin and milbemycin β1 from the milbemycin family to adriamycin-resistant human breast carcinoma cells(MCF-7 / adr). Methods MTT assay was used to evaluate the cell suppression rates and reversal effects. Intracellular accumulation of adriamycin was determined by HPLC. The accumulation of rhodamine 123(Rh123) was measured with spectrofluorometer. The expressions of P-gp and the MDR1 gene encoding P-gp were tested by flow cytometry and reverse-transcriptase PCR. Results Nemadectin and milbemycin β1at the high dose of 5 μmol·L- 1significantly increased the sensitivity of MCF-7 / adr cells to adriamycin. They also increased the intracellular accumulation of adriamycin and Rh123 in MCF-7 /adr cells in a dose-dependent manner. Expression of both P-gp and MDR1 was down-regulated to different level. Conclusion Nemadectin and milbemycin β1can partly reverse multidrug resistance of MCF-7 / adr,and the effect of nemadectin is better than that of milbemycin β1.
目的探讨奈马ectin和milbemycin β1对阿霉素耐药人乳腺癌细胞(MCF-7 / adr)的逆转作用。方法采用MTT法测定细胞抑制率和逆转作用。用高效液相色谱法测定阿霉素在细胞内的蓄积。用荧光分光光度仪测定罗丹明123(Rh123)的积累量。采用流式细胞术和逆转录酶PCR检测P-gp及编码P-gp的MDR1基因的表达。结果5 μmol·L- 1高剂量的奈马菌素和米霉素β1显著提高MCF-7 / adr细胞对阿霉素的敏感性。它们还以剂量依赖的方式增加了MCF-7 /adr细胞内阿霉素和Rh123的积累。P-gp和MDR1的表达均不同程度下调。结论奈马连素和米霉素β1能部分逆转MCF-7 / adr的多药耐药,且奈马连素的效果优于米霉素β1。
{"title":"Reversal effects of milbemycins on multidrug resistance in MCF-7/adr cells","authors":"Aili Gao, Hongsheng Liang, Zhao Wang, Shuai Liu, Qing Wang, Ning Zhao","doi":"10.3969/J.ISSN.1001-1978.2013.10.019","DOIUrl":"https://doi.org/10.3969/J.ISSN.1001-1978.2013.10.019","url":null,"abstract":"Aim To explore the reversal of MDR(multidrug resistance) by nemadectin and milbemycin β1 from the milbemycin family to adriamycin-resistant human breast carcinoma cells(MCF-7 / adr). Methods MTT assay was used to evaluate the cell suppression rates and reversal effects. Intracellular accumulation of adriamycin was determined by HPLC. The accumulation of rhodamine 123(Rh123) was measured with spectrofluorometer. The expressions of P-gp and the MDR1 gene encoding P-gp were tested by flow cytometry and reverse-transcriptase PCR. Results Nemadectin and milbemycin β1at the high dose of 5 μmol·L- 1significantly increased the sensitivity of MCF-7 / adr cells to adriamycin. They also increased the intracellular accumulation of adriamycin and Rh123 in MCF-7 /adr cells in a dose-dependent manner. Expression of both P-gp and MDR1 was down-regulated to different level. Conclusion Nemadectin and milbemycin β1can partly reverse multidrug resistance of MCF-7 / adr,and the effect of nemadectin is better than that of milbemycin β1.","PeriodicalId":10296,"journal":{"name":"中国药理学通报","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70068315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eukaryotic expression and functional activities of human soluble TNFR1-IgG membrane extracellular region(Fc) fusion protein using recombinant adenovirus 重组腺病毒对人可溶性TNFR1-IgG膜胞外区融合蛋白的真核表达及功能活性研究
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2013-08-01 DOI: 10.3969/J.ISSN.1001-1978.2013.08.014
Jia-jia Ma, N. Lu, Bi-liang Chen
{"title":"Eukaryotic expression and functional activities of human soluble TNFR1-IgG membrane extracellular region(Fc) fusion protein using recombinant adenovirus","authors":"Jia-jia Ma, N. Lu, Bi-liang Chen","doi":"10.3969/J.ISSN.1001-1978.2013.08.014","DOIUrl":"https://doi.org/10.3969/J.ISSN.1001-1978.2013.08.014","url":null,"abstract":"","PeriodicalId":10296,"journal":{"name":"中国药理学通报","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70068310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum metabonomic study on liuwei dihuang pills in the treatment of hyperthyroidism 六味地黄丸治疗甲亢的血清代谢组学研究
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2013-05-01 DOI: 10.3969/J.ISSN.1001-1978.2013.05.010
Bin Wang, Lan Shen, W. Cong, Yunyun Zhu, Qiang Wang, Yi Feng
Aim: To explore the underlying mechanism of hyperthyroidism induced by subcutaneous injection of L-levothyroxine sodium and and intervention effects of Liuwei Dihuang pills on sprague dawley rats via serum metabolomics. Methods: After rats were injected with L-levothyroxine sodium at a dosage of 35 μg·(100 g)-1 every day for 1 week,and then Liuwei dihuang pills(LDPs) were treated at a dose of 4.7 g·kg-1 for 3 consecutive weeks.The serum samples for rats were obtained after the treatment of LDPS and the metabolic profiles of serum were obtained with ultra performance liquid chromatography coupled with time-of-flight mass spectrometry(UPLC-QTOF-MS). Results: The levels of oxaloacetic acid,Dihydroxyacetone phosphate(DHAP),ethyl glucuronide,triglyceride,lysophospholipids and cholesterol were significantly increased in the model group as compared to the normal rats.Moreover,these levels could be regulated to be close to normal after the treatment of LDPS. Conclusions: There is severe disturbance in the tricarboxylic acid cycle as well as sugar and lipid metabolism for hyperthyroidism rats.LDPS can exhibite obvious effects on the treatment of hyperthyroidism.Serum metabonomics analysis reveals the changes of metabolites traits during the treatment of LDPS,thus providing a supplementary evaluation method of LDPS in the treatment of hyperthyroidism.
目的:通过血清代谢组学方法,探讨皮下注射左旋甲状腺素钠致大鼠甲状腺功能亢进的机制及六味地黄丸对大鼠甲状腺功能亢进的干预作用。方法:给大鼠注射左旋甲状腺素钠,剂量为35 μg·(100 g)-1,每天1周,然后给六味地黄丸,剂量为4.7 g·kg-1,连续3周。采用超高效液相色谱-飞行时间质谱法(UPLC-QTOF-MS)测定大鼠LDPS处理后的血清代谢谱。结果:与正常大鼠相比,模型组大鼠体内草酰乙酸、磷酸二羟丙酮(DHAP)、葡萄糖醛酸乙酯、甘油三酯、溶血磷脂、胆固醇水平均显著升高。而且,在LDPS治疗后,这些水平可以被调节到接近正常水平。结论:甲亢大鼠三羧酸循环及糖脂代谢存在严重紊乱。LDPS对甲亢的治疗效果明显。血清代谢组学分析揭示了LDPS治疗过程中代谢物性状的变化,从而为LDPS治疗甲亢提供了一种补充评价方法。
{"title":"Serum metabonomic study on liuwei dihuang pills in the treatment of hyperthyroidism","authors":"Bin Wang, Lan Shen, W. Cong, Yunyun Zhu, Qiang Wang, Yi Feng","doi":"10.3969/J.ISSN.1001-1978.2013.05.010","DOIUrl":"https://doi.org/10.3969/J.ISSN.1001-1978.2013.05.010","url":null,"abstract":"Aim: To explore the underlying mechanism of hyperthyroidism induced by subcutaneous injection of L-levothyroxine sodium and and intervention effects of Liuwei Dihuang pills on sprague dawley rats via serum metabolomics. Methods: After rats were injected with L-levothyroxine sodium at a dosage of 35 μg·(100 g)-1 every day for 1 week,and then Liuwei dihuang pills(LDPs) were treated at a dose of 4.7 g·kg-1 for 3 consecutive weeks.The serum samples for rats were obtained after the treatment of LDPS and the metabolic profiles of serum were obtained with ultra performance liquid chromatography coupled with time-of-flight mass spectrometry(UPLC-QTOF-MS). Results: The levels of oxaloacetic acid,Dihydroxyacetone phosphate(DHAP),ethyl glucuronide,triglyceride,lysophospholipids and cholesterol were significantly increased in the model group as compared to the normal rats.Moreover,these levels could be regulated to be close to normal after the treatment of LDPS. Conclusions: There is severe disturbance in the tricarboxylic acid cycle as well as sugar and lipid metabolism for hyperthyroidism rats.LDPS can exhibite obvious effects on the treatment of hyperthyroidism.Serum metabonomics analysis reveals the changes of metabolites traits during the treatment of LDPS,thus providing a supplementary evaluation method of LDPS in the treatment of hyperthyroidism.","PeriodicalId":10296,"journal":{"name":"中国药理学通报","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70068246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国药理学通报
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1